Literature DB >> 9566823

Liver failure associated with mitochondrial DNA depletion.

A A Morris1, J W Taanman, J Blake, J M Cooper, B D Lake, M Malone, S Love, P T Clayton, J V Leonard, A H Schapira.   

Abstract

BACKGROUND/AIMS: Liver failure in infancy can result from several disorders of the mitochondrial respiratory chain. In some patients, levels of mitochondrial DNA are markedly reduced, a phenomenon referred to as mitochondrial DNA depletion. To facilitate diagnosis of this condition, we have reviewed the clinical and pathological features in five patients with mitochondrial DNA depletion.
METHODS: Cases were identified by preparing Southern blots of DNA from muscle and liver, hybridising with appropriate probes and quantifying mitochondrial DNA relative to nuclear DNA.
RESULTS: All our patients with mitochondrial DNA depletion died of liver failure. Other problems included hypotonia, hypoglycaemia, neurological abnormalities (including Leigh syndrome) and cataracts. Liver histology showed geographic areas of fatty change, bile duct proliferation, collapse of liver architecture and fibrosis; some cells showed decreased cytochrome oxidase activity. Muscle from three patients showed mitochondrial proliferation, with loss of cytochrome oxidase activity in some fibres but not in others; in these cases, muscle mitochondrial DNA levels were less than 5% of the median control value. The remaining two patients (from a single pedigree) had normal muscle histology and histochemistry associated with less severe depletion of mitochondrial DNA in muscle.
CONCLUSIONS: Liver failure is common in patients with mitochondrial DNA depletion. Associated clinical features often include neuromuscular disease. Liver and muscle histology can be helpful in making the diagnosis. Mitochondrial DNA levels should be measured whenever liver failure is thought to have resulted from respiratory chain disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566823     DOI: 10.1016/s0168-8278(98)80278-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  14 in total

1.  Mitochondrial DNA depletion syndrome is expressed in amniotic fluid cell cultures.

Authors:  J C Blake; J W Taanman; A M Morris; R G Gray; J M Cooper; P J McKiernan; J V Leonard; A H Schapira
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 2.  Inborn errors of metabolism as a cause of neurological disease in adults: an approach to investigation.

Authors:  R G Gray; M A Preece; S H Green; W Whitehouse; J Winer; A Green
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

3.  Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome.

Authors:  Brian Bennett; Daniel Helbling; Hui Meng; Jason Jarzembowski; Aron M Geurts; Marisa W Friederich; Johan L K Van Hove; Michael W Lawlor; David P Dimmock
Journal:  Free Radic Biol Med       Date:  2016-01-08       Impact factor: 7.376

4.  Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion.

Authors:  P Hargreaves; S Rahman; P Guthrie; J W Taanman; J V Leonard; J M Land; S J R Heales
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

5.  Infantile mitochondrial DNA depletion syndrome associated with methylmalonic aciduria and 3-methylcrotonyl-CoA and propionyl-CoA carboxylase deficiencies in two unrelated patients: a new phenotype of mtDNA depletion syndrome.

Authors:  S Yano; L Li; T P Le; K Moseley; A Guedalia; J Lee; I Gonzalez; R G Boles
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 6.  Metabolic Liver Disease: When to Suspect and How to Diagnose?

Authors:  Seema Alam; Vikrant Sood
Journal:  Indian J Pediatr       Date:  2016-04-29       Impact factor: 1.967

7.  Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine.

Authors:  Bernhard Setzer; Dirk Lebrecht; Ulrich A Walker
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

8.  Influence of mitochondrial DNA level on cellular energy metabolism: implications for mitochondrial diseases.

Authors:  Christophe Rocher; Jan-Willem Taanman; Denis Pierron; Benjamin Faustin; Giovani Benard; Rodrigue Rossignol; Monique Malgat; Laurence Pedespan; Thierry Letellier
Journal:  J Bioenerg Biomembr       Date:  2008-04-16       Impact factor: 2.945

Review 9.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 10.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.